name,category,termsDEAD (Asp-Glu-Ala-Asp) box polypeptide 49,INTERPRO[450000537$IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450010405$IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012608$IPR014014:RNA helicase, DEAD-box type, Q motif, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,PIR_SUPERFAMILY[630026222$PIRSF034443:PIRSF034443]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001212$polymorphism, 790001339$rna-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,UP_SEQ_FEATURE[850041114$chain:Probable ATP-dependent RNA helicase DDX49, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117383$short sequence motif:DEAD box, 850117676$short sequence motif:Q motif]
collagen, type II, alpha 1,INTERPRO[450000772$IPR000885:Fibrillar collagen, C-terminal, 450000878$IPR001007:von Willebrand factor, type C, 450007490$IPR008160:Collagen triple helix repeat]
collagen, type II, alpha 1,KEGG_PATHWAY[470038853$hsa04510:Focal adhesion, 470038854$hsa04512:ECM-receptor interaction]
collagen, type II, alpha 1,OMIM_DISEASE[520000101$Achondrogenesis-hypochondrogenesis, type II, 520000393$Arthroophthalmopathy, progressive, 520000493$Avascular necrosis of the femoral head, 520001782$Epiphyseal dysplasia, multiple, with, 520001784$Epiphyseal dysplasia, multiple, with myopia and deafness, 520002747$Kniest dysplasia, 520002804$Legg-Calve-Perthes disease, 520003803$Osteoarthritis with mild chondrodysplasia, 520003852$Otospondylomegaepiphyseal dysplasia, 520004030$Platyspondylic skeletal dysplasia, Torrance type, 520004421$SED congenita, 520004422$SED, Namaqualand type, 520004517$SMD, 520004518$SMED Strudwick type, 520004663$Spondyloperipheral dysplasia, 520004695$Stickler sydrome, type I, nonsyndromic ocular, 520004696$Stickler syndrome, type I, 520005045$Vitreoretinopathy with phalangeal epiphyseal dysplasia]
collagen, type II, alpha 1,PIR_SUPERFAMILY[630002384$PIRSF002255:collagen alpha 1(I) chain]
collagen, type II, alpha 1,SMART[760000030$SM00038:COLFI, 760000187$SM00214:VWC]
collagen, type II, alpha 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000250$cartilage, 790000252$cataract, 790000344$coiled coil, 790000345$collagen, 790000356$complete proteome, 790000415$deafness, 790000445$direct protein sequencing, 790000446$disease mutation, 790000474$dwarfism, 790000530$extracellular matrix, 790000616$glycoprotein, 790000745$hydroxylation, 790000746$hydroxylysine, 790000747$hydroxyproline, 790001212$polymorphism, 790001289$pyroglutamic acid, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001446$stickler syndrome, 790001565$trimer, 790001568$triple helix]
collagen, type II, alpha 1,UP_SEQ_FEATURE[850011231$chain:Chondrocalcin, 850012176$chain:Collagen alpha-1(II) chain, 850103779$domain:Fibrillar collagen NC1, 850105643$domain:VWFC, 850105770$glycosylation site:N-linked (GlcNAc...), 850105818$glycosylation site:O-linked (Gal...), 850106258$modified residue, 850109670$propeptide:N-terminal propeptide, 850113762$region of interest:Nonhelical region (C-terminal), 850114937$region of interest:Triple-helical region, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118098$site:Cleavage; by procollagen C-endopeptidase, 850118099$site:Cleavage; by procollagen N-endopeptidase, 850118574$splice variant, 850118575$strand]
